"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Descriptor ID |
D013601
|
MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 12 | 8 | 20 |
1995 | 14 | 9 | 23 |
1996 | 8 | 6 | 14 |
1997 | 13 | 7 | 20 |
1998 | 15 | 6 | 21 |
1999 | 18 | 10 | 28 |
2000 | 4 | 9 | 13 |
2001 | 19 | 7 | 26 |
2002 | 16 | 17 | 33 |
2003 | 20 | 12 | 32 |
2004 | 18 | 12 | 30 |
2005 | 10 | 9 | 19 |
2006 | 17 | 6 | 23 |
2007 | 16 | 13 | 29 |
2008 | 10 | 7 | 17 |
2009 | 18 | 16 | 34 |
2010 | 10 | 12 | 22 |
2011 | 18 | 9 | 27 |
2012 | 11 | 15 | 26 |
2013 | 20 | 12 | 32 |
2014 | 17 | 18 | 35 |
2015 | 21 | 17 | 38 |
2016 | 13 | 17 | 30 |
2017 | 12 | 10 | 22 |
2018 | 16 | 13 | 29 |
2019 | 14 | 7 | 21 |
2020 | 17 | 9 | 26 |
2021 | 7 | 13 | 20 |
2022 | 8 | 13 | 21 |
2023 | 7 | 12 | 19 |
2024 | 1 | 6 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations. Immunohorizons. 2024 Jul 01; 8(7):492-499.
-
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity. Nat Commun. 2024 Jun 28; 15(1):5487.
-
Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med. 2024 May; 30(5):1448-1460.
-
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma. Lancet Oncol. 2024 05; 25(5):e205-e216.
-
Spatially resolved quantification of oxygen consumption rate in ex vivo lymph node slices. Analyst. 2024 Apr 29; 149(9):2609-2620.
-
PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape. Nat Immunol. 2024 May; 25(5):860-872.
-
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.
-
Base-editing mutagenesis maps alleles to tune human T cell functions. Nature. 2024 Jan; 625(7996):805-812.
-
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
-
CRISPR screens decode cancer cell pathways that trigger ?d T cell detection. Nature. 2023 Sep; 621(7977):188-195.